Cell Lysis Market Size, Share, and Trends Analysis, as well as Segment Forecasts, 2022-2030
![]() |
| Cell Lysis Market |
The
growing emphasis on the use of conducted electrical weapons (CEWs) will drive
the global stun gun market until the end of 2023. One of the primary reasons
for the use of CEWs is to incapacitate a hostile person by causing pain with an
electric current. In addition, when lethal force is not used to enforce human
rights laws, military personnel, police, and law enforcement agencies use CEWs.
Furthermore, stun guns with probes are effective against people who are high on
drugs or alcohol, making them less sensitive to pain. Furthermore, stun guns
are becoming more popular among military and law enforcement agencies because
they reduce the risk of fatality and can be used from a safer distance.
Global Cell
Lysis market is estimated to be valued at US$ 3,781.33 million in 2022 and
is expected to exhibit a CAGR of 8.6% during the forecast period (2022-2030).
The
first step in protein extraction is cell lysis, which is then used for a
variety of applications such as enzyme engineering and protein labelling.
Furthermore, cell lysis is an important step in studying protein-protein
interactions, which contributes to the growth of the cell lysis market. Players
in the global cell lysis market are focusing on R&D in order to introduce
advanced products used in the cell lysis process. Furthermore, rising demand
for cell-based therapy for cancer treatment is expected to drive growth in the market.
The
rising prevalence of cancer and other chronic diseases necessitates the use of
cell therapy techniques for precise treatment, which favours the growth of the market.
Furthermore, in order to meet the growing population's demand, the biotechnology
and biopharmaceutical industries are investing in research and development. For
example, CAR-T cell therapy was approved by the US Food and Drug Administration
in 2017 for the treatment of children with acute lymphoblastic leukaemia (ALL)
and adults with advanced lymphomas. Such additional research and development
outcomes support the growth of the market.

Comments
Post a Comment